ARS Pharmaceuticals (SPRY) Capital Expenditures (QoQ) (2020 - 2025)
ARS Pharmaceuticals (SPRY) Capital Expenditures (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | ARS Pharmaceuticals | 595.78 Mn | 394.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -195.70% |
| Jun 30, 2025 | 6,239.56% |
| Mar 31, 2025 | -69.87% |
| Dec 31, 2024 | 15.71% |
| Sep 30, 2024 | 414.46% |
| Jun 30, 2024 | -200.00% |
| Mar 31, 2024 | -1.19% |
| Jun 30, 2023 | -152.85% |
| Mar 31, 2023 | 53.17% |
| Dec 31, 2022 | 320.00% |
| Sep 30, 2022 | 36.36% |
| Jun 30, 2022 | 4.76% |
| Mar 31, 2022 | 102.55% |
| Dec 31, 2021 | -1,044.83% |
| Sep 30, 2021 | -87.57% |
| Jun 30, 2021 | 1,900.00% |
| Mar 31, 2021 | -85.83% |
| Dec 31, 2020 | -60.92% |
| Sep 30, 2020 | 12,540.00% |
| Jun 30, 2020 | -84.85% |